Your browser doesn't support javascript.
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.
Chaudhuri, Dipayan; Rochwerg, Bram.
  • Chaudhuri D; McMaster University, Hamilton, Ontario, Canada (D.C., B.R.).
  • Rochwerg B; McMaster University, Hamilton, Ontario, Canada (D.C., B.R.).
Ann Intern Med ; 175(2): JC18, 2022 02.
Article in English | MEDLINE | ID: covidwho-1716079
ABSTRACT
SOURCE CITATION Ortega-Paz L, Galli M, Capodanno D, et al. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19 a systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2021. [Epub ahead of print.] 34519777.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article